Show simple item record

dc.contributor.authorVunjak-Novakovic, Gordanaen_US
dc.contributor.authorBhatia, Sangeetaen_US
dc.contributor.authorChen, Christopheren_US
dc.contributor.authorHirschi, Karenen_US
dc.date.accessioned2015-01-05T18:28:34Z
dc.date.issued2010en_US
dc.identifier.citationVunjak-Novakovic, Gordana, Sangeeta Bhatia, Christopher Chen, and Karen Hirschi. 2010. “HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease.” Stem Cell Research & Therapy 4 (Suppl 1): S8. doi:10.1186/scrt369. http://dx.doi.org/10.1186/scrt369.en
dc.identifier.issn1757-6512en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:13581276
dc.description.abstractOur project team is developing an integrated microphysiological platform with functionally connected vascular, liver and cardiac microtissues derived from a single line of human pluripotent stem cells. The platform enables functional representation of human physiology in conjunction with real-time biological readouts (via imaging and homologous reporters for all three cell phenotypes) and compatibility with high-throughput/high-content analysis. In this paper, we summarize progress made over the first year of the grant.en
dc.language.isoen_USen
dc.publisherBioMed Centralen
dc.relation.isversionofdoi:10.1186/scrt369en
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029174/pdf/en
dash.licenseLAAen_US
dc.titleHeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and diseaseen
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden
dc.relation.journalStem Cell Research & Therapyen
dash.depositing.authorChen, Christopheren_US
dc.date.available2015-01-05T18:28:34Z
dc.identifier.doi10.1186/scrt369*
dash.contributor.affiliatedChen, Christopher


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record